Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Animals | 1 |
| Behavior | 1 |
| Brain | 1 |
| Cognitive Ability | 1 |
| Cognitive Processes | 1 |
| Death | 1 |
| Delivery Systems | 1 |
| Diabetes | 1 |
| Diagnostic Tests | 1 |
| Drug Therapy | 1 |
| Medical Research | 1 |
| More ▼ | |
Source
| Brain | 1 |
Author
| Ayer, Amit | 1 |
| Fine, Jared | 1 |
| Francis, George J. | 1 |
| Frey, William H., II | 1 |
| Glazner, Gordon | 1 |
| Hanson, Leah R. | 1 |
| Liu, Wei Q. | 1 |
| Martinez, Jose A. | 1 |
| Toth, Cory | 1 |
| Tuor, Ursula I. | 1 |
| Xu, Kevin | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkFrancis, George J.; Martinez, Jose A.; Liu, Wei Q.; Xu, Kevin; Ayer, Amit; Fine, Jared; Tuor, Ursula I.; Glazner, Gordon; Hanson, Leah R.; Frey, William H., II; Toth, Cory – Brain, 2008
Insulin deficiency in type I diabetes may lead to cognitive impairment, cerebral atrophy and white matter abnormalities. We studied the impact of a novel delivery system using intranasal insulin (I-I) in a mouse model of type I diabetes (streptozotocin-induced) for direct targeting of pathological and cognitive deficits while avoiding potential…
Descriptors: Delivery Systems, Diabetes, Brain, Cognitive Processes
